Carl Hull

Carl Hull

Executive Chairman and Former Interim Chief Executive OfficeratMaravai Lifesciences Holdings· In proxies 2021–2023

Pay in FY2023-5% from the year before · Maravai Lifesciences Holdings stock -54.2% the same year

Carl Hull was paid $5.2M in FY2023 (Dec), down 5%. Maravai Lifesciences Holdings stock fell 54.2% that year.

Pay$100 in the stock at the end of FY20 → $23
Pay is from the Summary Compensation Table of each Maravai Lifesciences Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Maravai Lifesciences HoldingsPublic company · 5 yr
    • Executive Chairman and Former Interim Chief Executive Officer2021 – Present · 5 yrStock in role -71%
  2. Ortho Clinical Diagnostics HoldingsPublic company · 1 yr
    • Director2021 – 2022 · 1 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?